What are Bio-Rad Laboratories's total assets?

Bio-Rad Laboratories (BIO) holds $9.8B in total assets, up 2.8% year over year.

How much debt does Bio-Rad Laboratories have?

Bio-Rad Laboratories carries $987.3M in total debt against $6.9B of shareholders' equity, a debt-to-equity ratio of 0.14.

How much cash does Bio-Rad Laboratories have?

Bio-Rad Laboratories holds $509.0M in cash and equivalents.

Can Bio-Rad Laboratories cover its short-term obligations?

Its current ratio is 3.21 — current assets exceed current liabilities.

Where does Bio-Rad Laboratories's balance sheet data come from?

Every line is extracted from Bio-Rad Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Bio-Rad Laboratories BIO Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$532.2M+8.7%	$489.8M+21.1%	$404.4M-6.9%	$434.54M-7.8%
Short-term investments	$1.01B-14.1%	$1.18B-2.2%	$1.2B-11.3%	$1.36B—
Restricted cash	——	$0-100%	$5.6M+0.7%	$5.56M—
Prepaid expenses and other current assets	$136.5M+11.3%	$122.6M-12.4%	$140M+12.7%	$124.18M+13.8%
Trading assets	$373.4M+17.6%	$317.5M-2.5%	$325.7M+1.0%	$322.6M-27.2%
Accrued investment income	$11.9M-9.2%	$13.1M+10.1%	$11.9M+2.6%	$11.6M+427%
Raw materials	$212.5M-4.3%	$222M-4.1%	$231.6M+1.2%	$228.8M+95.7%
Work in process	$234.9M-3.4%	$243.2M-1.1%	$246M+11.4%	$220.9M+11.6%
Finished goods	$293.3M-0.5%	$294.8M-2.7%	$302.9M+12.4%	$269.6M-13.8%
Total current assets	$2.91B-4.1%	$3.03B-0.6%	$3.05B-3.5%	$3.16B+58.7%
Property and equipment, net	$539.9M+2.2%	$528.1M-0.2%	$529M+6.1%	$498.61M-2.5%
Accumulated depreciation	$329.4M-27.1%	$451.9M+1.6%	$444.8M-55.9%	$1.01B+0.8%
Operating lease right-of-use assets	4.8%-16,049,999,995%	16,050,000,000%-3,420,000,000%	19,470,000,000%+1,374,800,000%	18,095,200,000%-2,384,600,000%
Goodwill	$579.8M+41.2%	$410.5M-0.7%	$413.6M+1.7%	$406.5M+17.0%
Intangible assets, net	$174.3M-40.6%	$293.6M-8.4%	$320.5M-3.5%	$332.15M+30.8%
Other non-current assets	$102.7M+0.8%	$101.9M+7.4%	$94.9M+0.3%	$94.6M-9.2%
Equity method investments	$23M-99.5%	$4.84B-37.1%	$7.7B-12.8%	$8.83B-38.6%
Long-term investments	$1.01B-14.1%	$1.18B+21,058%	$5.56M0.0%	$5.56M0.0%
Available-for-sale securities	——	——	——	——
Total assets	$10.58B+12.9%	$9.36B-23.9%	$12.3B-8.9%	$13.5B-24.1%
Accounts payable	$129M+5.5%	$122.3M-15.4%	$144.6M+7.1%	$135.04M-4.9%
Accrued expenses	$172.3M+38.7%	$124.2M-11.2%	$139.9M-28.2%	$194.79M-29.7%
Deferred revenue	$62.9M+2.3%	$61.5M-10.0%	$68.3M-5.0%	$71.9M+1.3%
Current portion of long-term debt	$500K+25.0%	$400K-20.0%	$500K0.0%	$500K0.0%
Operating lease liabilities, current	$36.1M-13.4%	$41.7M+3.2%	$40.4M+11.2%	$36.34M-0.3%
Finance Lease Liability, Current	$500K+25.0%	$400K-20.0%	$500K0.0%	$500K0.0%
Total current liabilities	$517M+10.5%	$467.8M-10.5%	$522.8M-8.1%	$568.71M-16.5%
Long-term debt	$1.2B+0.1%	$1.2B+0.1%	$1.2B+0.1%	$1.2B+11,292%
Operating lease liabilities, non-current	$145.7M+10.9%	$131.4M-20.6%	$165.5M+7.7%	$153.6M-12.7%
Finance Lease Liabilities (Total)	$9.2M-4.2%	$9.6M-5.0%	$10.1M-4.7%	$10.6M-3.6%
Operating Lease Liabilities (Total)	$181.8M+5.0%	$173.1M-15.9%	$205.9M+8.4%	$189.9M-10.6%
Finance lease liabilities	$8.7M-5.4%	$9.2M-4.2%	$9.6M-5.0%	$10.1M-3.8%
Other non-current liabilities	$199.1M+12.4%	$177.2M-9.1%	$195M-0.5%	$195.91M+7.5%
Total liabilities	$3.12B+11.7%	$2.79B-21.4%	$3.56B-8.5%	$3.89B-5.5%
Preferred stock	$0—	$0—	$0—	$0—
Additional paid-in capital	$476M+2.8%	$463.2M+3.1%	$449.1M+0.4%	$447.45M+1.3%
Retained earnings	$8.18B+10.2%	$7.42B-19.9%	$9.26B-6.4%	$9.9B-26.8%
Accumulated other comprehensive income (loss)	-$189.1M+64.9%	-$538.2M-60.2%	-$336M+28.0%	-$466.82M-166%
Treasury stock	$1.01B+30.8%	$772.1M+22.1%	$632.5M+140%	$263.59M—
Total stockholders' equity	$7.45B+13.5%	$6.57B-24.8%	$8.74B-9.1%	$9.62B-29.7%
Total liabilities and stockholders' equity	$10.58B+12.9%	$9.36B-23.9%	$12.3B-8.9%	$13.5B-24.1%
Available-for-Sale Debt Securities - Amortized Cost	——	——	——	——
Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)	——	——	——	——
Allowance for Doubtful Accounts Receivable (Current)	$5.5M-40.2%	$9.2M-38.4%	$14.93M-0.7%	$15.03M-0.7%
Cash, Cash Equivalents, and Marketable Securities	——	——	——	——
Finished goods	$293.3M-0.5%	$294.8M-2.7%	$302.9M+12.4%	$269.6M+4.8%
Other current assets	$27.7M-9.8%	$30.7M+17.6%	$26.1M+10.6%	$23.6M+134%
Trading Securities in Marketable Securities	$23M—	——	$8M—	——
Accumulated Goodwill Impairment Losses	$335.2M0.0%	$335.2M0.0%	$335.2M0.0%	$335.2M0.0%
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)	——	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$102.7M+0.8%	$101.9M+7.4%	$94.9M+0.3%	$94.6M-9.2%
Equity Securities Without Readily Determinable Fair Value - Cumulative Downward Adjustments	$23M—	——	$8M—	——
Accumulated Amortization on Finance Lease Assets	$6.4M+4.9%	$6.1M+3.4%	$5.9M+7.3%	$5.5M+7.8%
Intangible Assets Gross (Excluding Goodwill)	$503.7M-32.4%	$745.5M-2.6%	$765.3M+2.8%	$744.5M+12.3%
Investments - Amortized Cost Basis	$23M—	——	$8M—	——
Net Investment in Lease	$170M+5.9%	$160.5M-17.6%	$194.7M+7.6%	$180.95M-11.6%
Other intangible assets—net	$174.3M-40.6%	$293.6M-8.4%	$320.5M-3.5%	$332.15M+30.8%
Investments	$6.1B+26.1%	$4.84B-37.1%	$7.7B-12.8%	$8.83B-38.6%
Operating lease right-of-use assets	$170M+5.9%	$160.5M-17.6%	$194.7M+7.6%	$180.95M-11.6%
Other Assets	$102.7M+0.8%	$101.9M+7.4%	$94.85M+0.3%	$94.6M-7.9%
Other non-current assets	$102.7M+0.8%	$101.9M+7.4%	$94.9M+0.3%	$94.6M-9.2%
Property, plant and equipment, net	$539.9M+2.2%	$528.1M-0.2%	$529.01M+6.1%	$498.61M+1.6%
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$1.01B-14.1%	$1.18B-2.2%	$1.2B-11.3%	$1.36B+240%
Operating Lease Right-of-Use Assets in Other Assets	$170M+5.9%	$160.5M-17.6%	$194.7M+7.6%	$180.95M-11.6%
Software and Technology Licenses, Net	$102.7M+0.8%	$101.9M+7.4%	$94.9M+0.3%	$94.6M-9.2%
Accrued Manufacturing Costs	$172.3M+38.7%	$124.2M-11.2%	$139.9M-28.2%	$194.79M-29.7%
Accrued Income Taxes, Current	$36.6M+17.3%	$31.2M-12.8%	$35.8M+10.4%	$32.43M+214%
Deferred income	$48.9M+2.3%	$47.8M-6.5%	$51.1M-2.1%	$52.2M+2.7%
Compensation and benefits	$172.3M+38.7%	$124.2M-11.2%	$139.9M-28.2%	$194.79M-29.7%
Other accrued liabilities	$141.7M-3.7%	$147.2M-8.9%	$161.6M-4.7%	$169.65M+32.6%
Other Long Term Debt Current	$1.3M+8.3%	$1.2M+140%	$500K0.0%	$500K0.0%
Finance Lease Liability Payment Due	——	——	——	——
Finance Lease Liability - Undiscounted Excess Amount	——	——	——	——
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——
Lease Liability Payments - 2021	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	——	——	——
Lease Liability Payments - Due Year Two	——	——	——	——
Lease Liability Payments - Due Year Three	——	——	——	——
Lease Liability Payments - Due Year Four	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——
Notes Payable	$1.3M+8.3%	$1.2M+140%	$500K+7.5%	$465K-4.9%
Operating Lease Liability Payments Due	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	——	——	——
Standard Product Warranty Accrual	$6.1M-14.1%	$7.1M-15.5%	$8.4M-20.8%	$10.6M-16.5%
Debt Maturity - 5 to 10 Years	——	——	——	——
Operating Lease Liability Payments - 2027 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	——	——	——
Lease Liability Payments - Due After Year Five	——	——	——	——
Operating Lease Liability Payments - Thereafter (Lessee)	——	——	——	——
Total debt	$1.39B+0.7%	$1.38B-2.3%	$1.42B+1.2%	$1.4B+497%
Unrecognized Tax Benefits	$86.9M—	——	——	——
Convertible Preferred Stock Authorized Shares	7.5M0.0%	7.5M—	——	——
Convertible Preferred Stock Issued Shares	0—	——	——	——
Convertible Preferred Stock Outstanding Shares	0—	——	——	——
Cumulative Gross Losses and Impairments	$335.2M0.0%	$335.2M0.0%	$335.2M0.0%	$335.2M0.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Treasury Stock, Value	$1.01B+30.8%	$772.1M+22.1%	$632.5M+140%	$263.59M—
Preferred Stock Par Value Per Share	$0.00—	——	——	——
Cumulative Cost Basis	——	——	——	$1.51B-0.4%
Accounts Receivable, Allowance for Credit Loss	$5.5M-40.2%	$9.2M-38.3%	$14.9M-0.7%	$15M-0.7%
Allowance for doubtful accounts	$5.5M-40.2%	$9.2M-38.4%	$14.93M-0.7%	$15.03M-0.7%
Total	——	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10	——	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five	——	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One	——	——	——	——
Available for sale investments	——	——	——	——
Debt securities	——	$400M0.0%	$400M0.0%	$400M0.0%
Deferred income taxes	$1.06B+29.5%	$818M-44.6%	$1.48B-16.7%	$1.77B-42.2%
Derivative Forward Interest Rate	——	1.5%0.0%	1.5%0.0%	1.5%0.0%
Equity method investments (Note 11)	$36.9M+32.3%	$27.9M-13.6%	$32.3M—	——
Trading securities, cost	$23M—	——	$8M—	——
Current maturities of long-term debt	$500K+25.0%	$400K-20.0%	$500K0.0%	$500K0.0%
Finance Lease Liability Payments Due	——	——	——	——
Finance Lease Liability Payments Due After Year Five	——	——	——	——
2027	——	——	——	——
Finance Lease Liability Payments Due Year Four	——	——	——	——
Finance Lease Liability Payments Due Year Three	——	——	——	——
Finance Lease Liability Payments Due Year Two	——	——	——	——
Finance Lease Liability Undiscounted Excess Amount	——	——	——	——
Finance Lease, Right-of-Use Asset, Accumulated Amortization	$6.4M+4.9%	$6.1M+3.4%	$5.9M+7.3%	$5.5M+7.8%
Property, plant and equipment	$11.5M-1.7%	$11.7M-1.7%	$11.9M0.0%	$11.9M+0.8%
Finance Lease, Right-Of-Use Asset, after Accumulated Amortization	$5.1M-8.9%	$5.6M-6.7%	$6M-6.3%	$6.4M-4.5%
Finite-Lived Intangible Assets, Accumulated Amortization	$329.4M-27.1%	$451.9M+1.6%	$444.8M+7.9%	$412.4M+0.8%
Goodwill, Gross	$915M+22.7%	$745.7M-0.4%	$748.8M+1.0%	$741.7M+8.7%
Goodwill accumulated impairment losses	$335.2M0.0%	$335.2M0.0%	$335.2M0.0%	$335.2M0.0%
Indefinite- lived intangible impairment	$503.7M-32.4%	$745.5M-2.6%	$765.3M+2.8%	$744.5M+12.3%
Interest receivable on interest rate and cross currency swaps	$11.9M-9.2%	$13.1M+10.1%	$11.9M+2.6%	$11.6M+427%
Lessee Operating Lease Liability Payments Due	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	——	——
Fair value of long-term debt	$1.16B+5.0%	$1.11B-0.4%	$1.11B—	——
Notes and Loans Payable, Current	$1.3M+8.3%	$1.2M+140%	$500K+7.5%	$465K-4.9%
Operating Lease Weighted Average Discount Rate Percent	$0.05+17.1%	$0.04+5.1%	$0.04+30.0%	$0.03-9.1%
Preferred Stock, Par or Stated Value Per Share	$0—	——	——	——
Preferred Stock, Shares Authorized	$7.5M0.0%	$7.5M—	——	——
Preferred Stock, Shares Issued	$0—	——	——	——
Preferred Stock, Shares Outstanding	$0—	——	——	——
Prepaid expenses	$136.5M+11.3%	$122.6M-12.4%	$140M+12.7%	$124.18M+13.8%
Standard and Extended Product Warranty Accrual	$6.1M-14.1%	$7.1M-15.5%	$8.4M-20.8%	$10.6M-16.5%
Unrecognized tax benefits	$86.9M+0.2%	$86.7M+2.4%	$84.7M-0.9%	$85.5M+38.1%
Remainder of Fiscal Year 2024	——	——	——	——
Weighted-Average Discount Rate	6.7%+0.2%	6.5%+0.1%	6.4%+0.1%	6.3%0.0%
Weighted-Average Discount Rate - Finance Leases	$0.07+3.1%	$0.07+1.6%	$0.06+1.6%	$0.060.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bio-Rad Laboratories.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Bio-Rad Laboratories's total assets?: Bio-Rad Laboratories (BIO) holds $9.8B in total assets, up 2.8% year over year.
How much debt does Bio-Rad Laboratories have?: Bio-Rad Laboratories carries $987.3M in total debt against $6.9B of shareholders' equity, a debt-to-equity ratio of 0.14.
How much cash does Bio-Rad Laboratories have?: Bio-Rad Laboratories holds $509.0M in cash and equivalents.
Can Bio-Rad Laboratories cover its short-term obligations?: Its current ratio is 3.21 — current assets exceed current liabilities.
Where does Bio-Rad Laboratories's balance sheet data come from?: Every line is extracted from Bio-Rad Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.